*Mission*
Elsevier is committed to making genuine contributions to the science and
health communities.
Elsevier. Building Insights. Breaking Boundaries.

 Home </wps/find/homepage.cws_home> | Site map
</wps/find/sitemap.cws_home/sitemap> | Elsevier websites
</wps/find/elsevierwebsites.cws_home/elsevierwebsites> | Alerts
</wps/find/home_content.cws_home/alertingservices>
	Elsevier 		

	Product information search 	
	Search all Elsevier sites 	
Search <javascript:submitSearchForm(document.forms['searchForm'])> 	
Advanced Product Search
</wps/find/advproductsearch.cws_home?action=product_search&search=no>

	

Go to Elsevier home page </wps/find/homepage.cws_home>

	
	Products
</wps/find/subject_area_browse.cws_home/?sh1State=-null-SAR-SAA-SAC-SAD-SAF-SA1-SAI-SAJ-SAK-SAQ-SAP-SAB-SAE-SAL-SAN-SAO-SAG-SAH-SAM&sh2State=&allParents=y&showAll=y>
	

	Genomics
</wps/find/journaldescription.cws_home/622838/authorinstructions?navopenmenu=-2>
	

	Journal information

	Product description
</wps/find/journaldescription.cws_home/622838/description#description> 	

	Editorial board
</wps/find/journaleditorialboard.cws_home/622838/editorialboard#editorialboard>
	

	Abstracting/indexing
</wps/find/journalabstracting.cws_home/622838/abstracting#abstracting> 	

	Subscription information

	Bibliographic and ordering information
</wps/find/journalbibliographicinfo.cws_home/622838/description#bibliographicinfo>
	

	Conditions of sale
</wps/find/journalconditionsofsale.cws_home/622838/conditionsofsale#conditionsofsale>
	

	Dispatch dates
</wps/find/journaldispatchdates.cws_home/622838/dispatchdates#dispatchdates>
	

	Journal-related information

	Contact the publisher
</wps/find/journalcontactpublisher.cws_home/622838/contactpublisher#contactpublisher>
	

	Impact factor
</wps/find/journalimpactfactors.cws_home/622838/description#impactfactors> 	

	Most downloaded articles
<javascript:openWindow("http://top25.sciencedirect.com/?journal_id=08887543","topdownload")>
	

	Other journals in same subject area
</wps/find/products_in_subject_and_group.cws_home/622838> 	

	Support & contact </wps/find/supportfaq.cws_home/overview> 	

	About Elsevier </wps/find/intro.cws_home/ataglance> 	

	Select your view
</wps/find/journaldescription.cws_home/622838/authorinstructions?navopenmenu=4>
	

	

			
	
	GENOMICS	
		
	
*IMPACT FACTOR 3.558*, Journal Citation Reports© 2007, published by
Thomson Scientific



*Guide for Authors*

The goal of /Genomics/ is to promote the understanding of the structure,
function, and evolution of genomes in all kingdoms of life and the
application of genome sciences and technologies to challenging problems
in biology and medicine. The scope of the journal is broad and we
welcome original, full-length, and timely papers in all of the following
areas:

• Comparative genomics analysis that yields valuable insights into
conserved and divergent aspects of function, regulation, and evolution

• Bioinformatics and computational biology with particular emphasis on
data mining and improvements in data annotation and integration

• Functional genomics approaches involving the use of large-scale and/or
high-throughput methods to understand genome-scale function and
regulation of transcriptomes and proteomes

• Identification of genes involved in disease and complex traits,
including responses to drugs and other xenobiotics

• Significant advances in genetic and genomics technologies and their
applications, including chemical genomics

Readers are invited to submit ideas and proposals for reviews and
minireviews; they should not submit complete or finished manuscripts
prior to consultation with the editor-in-chief or one of the associate
editors.

Short communications are not encouraged. Single-gene reports will not be
considered unless they are accompanied by significant or novel insights
into their structure, evolution, and/or expression. With respect to
single genes, functional assertions should be supported by experimental
evidence; e.g., functional inferences based solely on routine analysis
of homology are insufficient. Authors are encouraged to identify and
report any discrepancies between their findings and annotations in the
major genome databases.

Manuscripts are accepted for review with the understanding that no
substantial portion of the study has been published nor is under
consideration for publication elsewhere, and that its submission for
publication has been approved by all of the authors and by the
institution where the work was carried out. Manuscripts that do not meet
the general criteria or standards for publication in /Genomics/ will be
immediately returned to the authors, without detailed review.

*Submission of manuscripts*

Manuscripts must be written in English. There are no submission fees or
page charges.

Submission to this journal proceeds totally online via the following
link External link http://www.ees.elsevier.com/geno. The system
automatically converts source files to a single Adobe Acrobat PDF
version of the article, which is used in the peer-review process. Please
note that even though manuscript source files are converted to PDF at
submission for the review process, these source files are needed for
further processing after acceptance. All correspondence, including
notification of the Editor's decision and requests for revision, takes
place by e-mail and via the author's home page, removing the need for a
hard-copy paper trail.

Each manuscript should be accompanied by a letter outlining the basic
findings of the paper and their significance. Authors should suggest an
appropriate associate editor (see Editorial Board for a list of names at
External link http://www.elsevier.com/locate/ygeno) and possible
reviewers (up to five, with contact details) in their field.

*Copyright.* Upon acceptance of an article, authors will be asked to
transfer copyright (for more information on copyright, see
http://authors.elsevier.com). This transfer will ensure the widest
possible dissemination of information. A letter will be sent to the
corresponding author confirming receipt of the manuscript. A form
facilitating transfer of copyright will be provided after acceptance.

If material from other copyrighted works is included, the author(s) must
obtain written permission from the copyright owners and credit the
source(s) in the article. Elsevier has preprinted forms for use by
authors in these cases: contact Elsevier Global Rights Department, P.O.
Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865
853333, e-mail: permissions@elsevier.com <mailto:permissions@elsevier.com>.

* /Genomics/ publishes the following:*

*Articles.* Organization should be Abstract, Introduction, Results,
Discussion, Materials and methods, Acknowledgments, and References.
There is a limit of 8 display items (figures plus tables) and 50
references. Manuscripts should be no more than 8 /published/ pages.
Accepted papers that are over 8 pages may be returned to the authors for
additional editing. *Manuscript length* can be estimated by the total
number of characters (spaces included), not the number of typed pages.
The average number of characters per published page is approximately
7000. Count each table or figure as 2450 characters and add to the
character count of your manuscript text. In other words, a regular
submission should have no more than 56,000 characters (that is, 8
published pages).

*Minireviews.* The journal encourages the submission of concise, highly
focused review articles summarizing recent progress in very active areas
of research involving the analysis of genomes. Authors wishing to
prepare such reviews should submit a short proposal, including an
expected date of submission, to the editor.

*Special features.* In addition to minireviews, special reviews of
research programs for mapping and sequencing, historical sketches,
genomics news, etc., are published periodically.

*Preparation of manuscripts*

Manuscripts should be double-spaced throughout. Pages should be numbered
consecutively and organized as follows:

    * The *title page* (p. 1) should contain the article title (20 words
      or less), authors' names and complete affiliations, and the
      address for manuscript correspondence (including e-mail address
      and telephone and fax numbers). Affiliations should be footnoted
      using superscripted, lowercase Arabic letters (e.g., a, b, c, etc.).
    * The *Abstract* (p. 2) must be a single paragraph that summarizes
      the main findings of the paper in less than 150 words. After the
      abstract a list of up to 10 *keywords* that will be useful for
      indexing or searching should be included (please use MeSH
      terminology; see External link
      http://www.nlm.nih.gov/mesh/meshhome.html). The Abstract should
      not be referenced.
    * The *Introduction* should be as concise as possible, without
      subheadings.
    * *Results* and *Discussion* may be combined and may be organized
      into subheadings.
    * *Materials and methods* should be sufficiently detailed to enable
      the experiments to be reproduced. Names of manufacturers and their
      locations should be provided in parentheses.
    * *Acknowledgments* should be brief and should precede the
      references. Individuals should be referred to by their full first
      name and surname, with their affiliation in parentheses. Titles
      (Dr., Professor, Mrs., etc.) are not permitted.



*References* should be cited in the text in numerical order (1, 2,
3,..., /n/). Reference numbers should be enclosed in brackets (for
example, "Jones and colleagues [3] found that...") and should precede
figure callouts. Arrange the reference list in numerical order as the
references occur in the text, followed by those in the figure legends
and tables. For references with 6 or more authors, please list only the
first author followed by et al. Only articles that have been published
or are in press should be included in the references. Unpublished
results or personal communications should be cited as such in the text.
Personal communications must include the date and the affiliation of the
person communicating the material. Submitted manuscripts should not be
cited in the reference list, but instead inserted in the text as
follows: (J. Smith and R. Davis, manuscript submitted). The names of
journals should be abbreviated according to the most recent edition of
the /List of Journals Indexed in Index Medicus/ (External link
http://www.nlm.nih.gov/tsd/serials/lji.html). Please note the following
examples.


(Book)
[1] N. Hagag, M.V. Viola, Chromosome Microdissection and Cloning: A
Practical Guide, Academic Press, San Diego, 1993.


(Book Chapter)
[2] U. Reichert, S. Michel, R. Schmidt, The cornified envelope: a key
structure of terminally differentiating keratinocytes, in: M. Darmon, M.
Blumenberg (Eds.), Molecular Biology of the Skin: The Keratinocyte,
Academic Press, San Diego, 1993, pp. 107–150.


(Journal)
[3] M.A. Curran, S.M. Kaiser, P.L. Achacoso, G.P. Nolan, Efficient
transduction of nondividing cells by optimized feline immunodeficiency
virus vectors, Mol. Ther. 1 (2000) 31–38.

*Nomenclature, abbreviations, and symbols.* Authors must use approved
nomenclature for all genes, and all manuscripts will undergo a
nomenclature check prior to publication. All unapproved symbols must be
replaced with approved symbols (throughout the text and figures). To
avoid delays to your manuscript please obtain approval for any new gene
symbols prior to submitting your manuscript. Copies of emails
documenting the approval of any new symbols should accompany all
submissions. Approved human gene symbols may be obtained before
submission from the HUGO Gene Nomenclature Committee (HGNC: contact Dr
Elspeth Bruford, EMBL-European Bioinformatics Institute, Wellcome Trust
Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK); e-mail:
hgnc@genenames.org <mailto:hgnc@genenames.org>; External link
http://www.genenames.org/. Approved mouse nomenclature may be obtained
before submission from L. J. Maltais, The Jackson Laboratory, Bar
Harbor, ME 04609-0800, USA; telephone: (207) 288-6429; fax: (207)
288-6132; e-mail: ljm@informatics.jax.org
<mailto:ljm@informatics.jax.org>; External link
http://www.informatics.jax.org/nomen/. In mouse, mutant strains and
transgenic alleles also require approved symbols; see External link
http://www.informatics.jax.org/. /Use of unapproved gene symbols will
likely delay publication./

Human and mouse protein symbols should be denoted in all capital letters
(for example, FGF8). Use of "h" and "m" prefixes to distinguish between
human and mouse proteins is not permitted. Instead, "mouse" or "human"
should be inserted before the relevant protein symbol in cases where it
is necessary to distinguish between human and mouse proteins. (This
protocol extends to proteins of all other organisms.)

Authors must use SI units and follow the guidelines for abbreviations
and symbols of the IUPAC-IUBMB Joint Commission on Biochemical
Nomenclature (External link http://www.chem.qmw.ac.uk/iupac/jcbn/).

*DNA sequences and GenBank accession numbers.* Authors wishing to enable
other scientists to use the accession numbers cited in their papers via
links to these sources should type this information in the following
manner: For each and every accession number cited in an article, authors
should type the accession number in bold, underlined text. Letters in
the accession number should always be capitalized (see example below).
This combination of letters and format will enable the typesetter to
recognize the relevant texts as accession numbers and add the required
link to GenBank sequences.

/Example:/ GenBank accession nos. _ *AI631510* _, _ *AI631511* _, _
*AI632198* _, and _ *BF223228* _), a B-cell tumor from a chronic
lymphatic leukemia (GenBank accession no. _ *BE675048* _), and a T-cell
lymphoma (GenBank accession no. _ *AA361117* _).

Authors are encouraged to check accession numbers used very carefully.
An error in a letter or number can result in a dead link.

In the final version of the /printed article/, the accession number text
will not appear bold or underlined. In the final version of the
/electronic/ copy, the accession number text will be linked to the
appropriate source in the NCBI databases, enabling readers to go
directly to that source from the article.

*Figures.* In the interest of quality and accuracy, we prefer to use
author-supplied electronic artwork for all figures and complex tables.
Each individual figure or graphic must be supplied as a separate,
stand-alone file. Figure and table files must be named with their
respective numbers and graphic types such as SmithFig1.tif,
SmithFig2a.tif, SmithTable1.eps, etc. Long file names are acceptable.

Use EPS or TIFF file formats; TIFF is preferred. Artwork submitted in
TIFF should adhere to the following resolution settings: halftones
(color/grayscale): 300 dpi; line art (black and white) and mixed images
(halftones with text or line art): 600 to 1200 dpi. If it is necessary
to import graphics from a vector-based drawing program (e.g., Adobe
Illustrator) into a raster-based program (e.g., Adobe PhotoShop) in
order to produce a TIFF file, a resolution of at least 600 dpi is
required for quality reproduction.

When creating your figures, use font sizes and line weights that will
reproduce clearly and accurately when figures are sized to the
appropriate column width. The minimum line weight is 1/2 point (thinner
lines will not reproduce well). Eliminate all excess white space from
the borders of each figure. Do not include figure legends or other
extraneous text in a graphic file; figure legends should be provided as
text, placed after the reference section in the main manuscript file.
Number figures consecutively with Arabic numerals.

*Color figures.* One piece of color art per article will be published
free of charge, provided color is deemed scientifically necessary by the
reviewers and the editor. Additional color figures in print will be
charged to the author, unless color is required by the editor. However,
if together with your accepted article you submit usable color figures,
then Elsevier will ensure, at no additional charge, that these figures
will appear in color on the Web (e.g., ScienceDirect and other sites)
regardless of whether these illustrations are reproduced in color in the
printed version. For further information on the preparation of
electronic artwork, please see http://authors.elsevier.com/artwork.

Please note: Because of technical complications that can arise in
converting color figures to "gray scale" (for the printed version should
you not opt for color in print), please submit in addition usable
black-and-white files corresponding to all the color illustrations.

*Cover art.* Authors submitting a manuscript for consideration may also
submit color figures for exclusive use as cover illustrations. These
figures do not need to relate to the manuscript being submitted, but
should relate to the larger scope and focus of /Genomics./ Submit art in
electronic form (TIFF and EPS files only). A short (one-line) legend
should accompany each photograph.

*Tables.* Tables should be numbered consecutively with Arabic numerals
(1, 2, 3, etc.) in the order in which they are referred to in the text.
Type each table (double-spaced) on a separate page (not embedded in the
text) with a short descriptive title typed directly above and with
essential footnotes below. Table footnotes should be denoted using
superscript lowercase Arabic letters (a, b, c, etc.), not symbols.
Authors must submit tables in Microsoft Word format.

*Preparation of supplementary material*

Supplementary files offer additional possibilities for publishing
supporting applications, movies, animation sequences, high-resolution
images, background datasets, sound clips, and more. Supplementary files
supplied will be published online alongside the electronic version of
your article in Elsevier Web products, including ScienceDirect
(http://www.sciencedirect.com). To ensure that your submitted material
is directly usable, please provide the data in one of our recommended
file formats. Authors should submit the material in electronic format
together with the article and supply a concise and descriptive caption
for each file. Please note, however, that supplementary material will
not appear in the printed journal. For more detailed instructions,
please visit External link http://www.authors.elsevier.com/artwork.

*Proofs*

PDF proofs will be sent by e-mail to the corresponding author. Upon
acceptance, the manuscript will be edited according to the style of the
journal, and proofs should be reviewed carefully. Please be sure to
answer all author queries. To avoid delay in publication, only necessary
changes should be made, and proof corrections should be returned within
*2 business days.* Failure to do so will result in publication delays.

*Sharing information and materials*

It is expected that all new biological or other reagents described in
papers published in /Genomics/ will be made available freely to all
qualified members of the scientific community upon written request. If
delays in strain or vector distribution are anticipated, or if these are
available from sources other than the author(s), this must be indicated
and, if the editor thinks it necessary, explained.

*Submission of data to databases*

The editorial policy of /Genomics/ is to require the use of databases.
Deposit of data in the appropriate database(s) is a condition of
publication. New nucleotide data must be submitted and deposited in the
DDBJ/EMBL/GenBank databases and an accession number obtained before the
paper can be accepted for publication. Submission to any one of the
three collaborating databanks is sufficient to ensure data entry in all.
The accession number should be included in the manuscript as a footnote
on the title page: "Sequence data from this article have been deposited
with the DDBJ/EMBL/GenBank Data Libraries under Accession No. ...." If
requested, the database will withhold release of data until publication.
The most convenient method for submitting sequence data is by the World
Wide Web:

DDBJ via SAKURA, External link http://sakura.ddbj.nig.ac.jp/
EMBL via WEBIN, External link
http://www.ebi.ac.uk/embl/Submission/webin.html
GenBank via BankIt, External link http://www.ncbi.nlm.nih.gov/BankIt/
Stand-alone submission tool Sequin, External link
http://www.ncbi.nlm.nih.gov/Sequin/
Mouse Genome Informatics, External link
http://www.informatics.jax.org/mgihome/

For special types of submissions (for example, genomes, bulk
submissions), additional submission protocols are available from the
above sites. Database contact information:

/DDBJ/:
Center for Information Biology and DNA Data Bank of Japan
National Institute of Genetics
1111 Yata
Mishima, Shizuoka 411-8540, Japan
Telephone: 81 55981 6853; Fax: 81 55981 6849
E-mail: ddbj@ddbj.nig.ac.jp <mailto:ddbj@ddbj.nig.ac.jp>
Web URL: External link http://www.ddbj.nig.ac.jp/

/EMBL/
EMBL Nucleotide Sequence Submissions
European Bioinformatics Institute
Wellcome Trust Genome Campus
Hinxton, Cambridge CB10 1SD, UK
Telephone: 44 1223 494499; Fax: 44 1223 494472
E-mail: datasubs@ebi.ac.uk <mailto:datasubs@ebi.ac.uk>
Web URL: External link http://www.ebi.ac.uk

/GenBank/
National Center for Biotechnology Information
National Library of Medicine
Building 38A, Room 8N-802
Bethesda, MD 20894, USA
Telephone: (301) 496-2475; Fax: (301) 480-9241
E-mail: info@ncbi.nlm.nih.gov <mailto:info@ncbi.nlm.nih.gov>
Web URL: External link http://www.ncbi.nlm.nih.gov

*US National Institutes of Health (NIH) voluntary posting (" Public
Access") policy*

Elsevier facilitates author response to the NIH voluntary posting
request (referred to as the NIH "Public Access Policy"; see
http://www.nih.gov/about/publicaccess/index.htm) by posting the
peer-reviewed author's manuscript directly to PubMed Central on request
from the author, 12 months after formal publication. Upon notification
from Elsevier of acceptance, we will ask you to confirm via e-mail (by
e-mailing us at NIHauthorrequest@elsevier.com
<mailto:NIHauthorrequest@elsevier.com>) that your work has received NIH
funding and that you intend to respond to the NIH policy request, along
with your NIH award number to facilitate processing. Upon such
confirmation, Elsevier will submit to PubMed Central on your behalf a
version of your manuscript that will include peer-review comments, for
posting 12 months after formal publication. This will ensure that you
will have responded fully to the NIH request policy. There will be no
need for you to post your manuscript directly with PubMed Central, and
any such posting is prohibited.

*Author inquiries*

Authors can also keep track of the progress of their accepted articles
and set up e-mail alerts informing them of changes to their manuscript
status by using Elsevier's article tracking service at External link
http://www.elsevier.com/trackarticle. Contact details for questions
arising after acceptance of an article, especially those relating to
proofs, are provided when an article is accepted for publication.

*Sponsored Articles:*
Genomics offers authors or their institutions the option to sponsor
non-subscriber access to their articles on Elsevier's electronic
publishing platforms. For more information please click here
<http://www.elsevier.com/wps/find/authorshome.authors/ygeno>.

	
		

		

		
	
Printer-friendly version <javascript:openPrinterFriendlyPage()>
  Printer-friendly version <javascript:openPrinterFriendlyPage()>

	

		

		
	
	
 Home </wps/find/homepage.cws_home> | Site map
</wps/find/sitemap.cws_home/sitemap> | Privacy policy
</wps/find/privacypolicy.cws_home/privacypolicy> | Terms and Conditions
</wps/find/termsconditions.cws_home/termsconditions> | Feedback
</wps/find/feedbackform.cws_home> | A Reed Elsevier
<http://www.reed-elsevier.com> company 	
 Copyright © 2007 Elsevier B.V. </wps/find/homepage.cws_home> All rights
reserved.

	

